Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2013
05/30/2013WO2013020714A3 Cell- or virus simulating means comprising encapsulated marker molecules
05/30/2013WO2013014405A3 Methods of inhibiting inflammation comprising inhibiting cd63
05/30/2013WO2013009143A3 Marker for diagnosing diabetic retinopathy
05/30/2013WO2012177639A3 Bioprocessing and bioproduction using avian cell lines
05/30/2013WO2012174378A3 Methods and materials for assessing allelic imbalance
05/30/2013WO2012027395A3 Cellulosic processing trait development using a thermoregulated, intein-modified xylanase
05/30/2013US20130139284 Plants and Polynucleotides Encoding Truncated Cry34 Proteins
05/30/2013US20130139281 Transgenic Plants with Increased Stress Tolerance and Yield
05/30/2013US20130139280 Plants Having Enhanced Yield-Related Traits and a Method for Making the Same
05/30/2013US20130139279 Wuschel (wus) gene homologs
05/30/2013US20130139278 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics and phenotypes
05/30/2013US20130139276 Discovery and utilization of sorghum genes (ma5/ma6)
05/30/2013US20130137758 Akt activity specifically inhibiting polypeptide
05/30/2013US20130137754 Tumor therapy with replication competent sindbis viral vectors
05/30/2013US20130137752 RNA Interference Mediated Inhibition of Catenin (Cadherin-Associated Protein), Beta 1 (CTNNB1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
05/30/2013US20130137751 Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf
05/30/2013US20130137750 Double stranded rna compounds to rhoa and use thereof
05/30/2013US20130137748 Whsc1 and whsc1l1 for target genes of cancer therapy and diagnosis
05/30/2013US20130137747 Double-stranded rna-based nanoparticles for insect gene silencing
05/30/2013US20130137606 Non-Emulsion Methods and Masked Biomolecules
05/30/2013US20130137605 Sequence tag directed subassembly of short sequencing reads into long sequencing reads
05/30/2013US20130137601 Laminar library screen
05/30/2013US20130137600 Laminar library screen
05/30/2013US20130137181 Ethanol-Resistant Yeast Gene, and Use Thereof
05/30/2013US20130137180 Genome editing using targeting endonucleases and single-stranded nucleic acids
05/30/2013US20130137149 Production of biodiesel by yeast from lignocellulose and glycerol
05/30/2013US20130137146 Methods for nucleic acid manipulation
05/30/2013US20130137145 Methods for nucleic acid manipulation
05/30/2013US20130137141 Production cell line
05/30/2013US20130137140 Increased protein expression through increased membrane formation
05/30/2013US20130137118 Integrin heterodimer and a subunit thereof
05/30/2013US20130137104 Methods and compositions for modification of the hprt locus
05/30/2013US20130137101 Methods of Modifying Eukaryotic Cells
05/30/2013US20130137100 Genetically modified bacterium of the species listeria monocytogenes
05/30/2013US20130136825 Enzymes
05/30/2013US20130136786 Long non-coding rna spry4-it1 as a diagnostic and therapeutic agent
05/30/2013US20130136768 Recombinant HCMV and RHCMV vectors and uses thereof
05/30/2013US20130136767 Compositions, methods and uses for poxvirus elements in vaccine constructs
05/30/2013US20130136762 Modified surface antigen
05/30/2013US20130136760 Streptococcus pyogenes antigens and corresponding dna fragments
05/30/2013US20130136751 Methods, Compositions and Kits Relating to Chitnases and Chitnase-Like Molecules and Inflammation Disease
05/30/2013US20130136749 Human CTLA-4 Antibodies And Their Uses
05/30/2013US20130136747 Anti-amyloid beta antibodies and their use
05/30/2013US20130136745 Soluble endoglin and uses thereof
05/30/2013CA2856676A1 Mutant xylanase, manufacturing method and use therefor, and method for manufacturing saccharified lignocellulose
05/30/2013CA2856593A1 Polypeptides having lysozyme activity and polynucleotides encoding same
05/30/2013CA2856485A1 Plant transformant, transformation method for plant, and vector used in said method
05/30/2013CA2856351A1 Method for highly expressing recombinant protein of engineering bacteria and use thereof
05/30/2013CA2856297A1 Binding molecules specific for her3 and uses thereof
05/30/2013CA2856137A1 Virus vectors for highly efficient transgene delivery
05/30/2013CA2855699A1 Anti-human trop-2 antibody having an antitumor activity in vivo
05/30/2013CA2855171A1 Diterpene synthases and method for producing diterpenoids
05/30/2013CA2854363A1 Compositions and methods for increasing nematode resistance in plants
05/30/2013CA2854255A1 Mutations of histone proteins associated with proliferative disorders
05/30/2013CA2852389A1 Plants having enhanced yield-related traits and method for making the same
05/30/2013CA2852388A1 Plants having enhanced yield-related traits and method for making the same
05/29/2013EP2597464A2 Metabolomic profiling of prostate cancer
05/29/2013EP2597162A1 Nucleic acid detection
05/29/2013EP2597155A1 Methods and compositions for targeted integration
05/29/2013EP2597154A1 LCMV-GP-VSV pseudotype vectors and tumour infiltrating virus producing cells for treating tumours
05/29/2013EP2597152A1 Genetically engineered strain wsj-ia for producing isovaleryl spiramycin i.
05/29/2013EP2597151A2 Recombinant microorganisms, methods for preparing vaccine strains, antigens, and vector vaccine compositions of same, uses thereof, and related antibodies, diagnostic kit, and treatment and/or prophylactic methods
05/29/2013EP2596807A1 Complement binding aptamers and anti-C5 agents useful in the treatment of ocular disorders
05/29/2013EP2596137A1 A method for producing an l- amino acid using a bacterium of the enterobacteriaceae family with enhanced expression of the bssr gene
05/29/2013EP2596136A1 Marker consisting of plasma microrna and new method for diagnosis of hepatocellular carcinoma
05/29/2013EP2596106A2 Plant-based production of heterologous proteins
05/29/2013EP2596105A2 Plants having enhanced yield-related traits and a method for making the same
05/29/2013EP2596104A1 FERULOYL-CoA:MONOLIGNOL TRANSFERASE
05/29/2013EP2596103A1 FERULOYL-CoA:MONOLIGNOL TRANSFERASE
05/29/2013EP2596102A2 Sequence specific double-stranded dna/rna binding compounds and uses thereof
05/29/2013EP2596101A1 Genome editing using targeting endonucleases and single-stranded nucleic acids
05/29/2013EP2596100A1 Process
05/29/2013EP2596099A1 Method for harvesting expression products
05/29/2013EP2596028A1 Compositions and methods for controlled release of biomolecules
05/29/2013EP2596025A1 Methods for cancer management targeting co-029
05/29/2013EP2596023A2 Compositions and methods featuring il-6 and il-21 antagonists
05/29/2013EP2596013A1 Nkx2.2 inhibitors as drugs
05/29/2013EP2595664A2 Modulation of nuclear-retained rna
05/29/2013EP2595663A2 Modulation of dystrophia myotonica-protein kinase (dmpk) expression
05/29/2013EP2595652A1 Parapoxvirus vectors
05/29/2013EP2595644A1 Amyloid-beta clearance
05/29/2013EP2595473A2 Transgenic plants expressing a viral antifungal protein
05/29/2013DE102004013826B4 Hyphenspezifische Zellwandproteine in Candida Hyphenspezifische cell wall proteins in Candida
05/29/2013DE10017526B4 Standardprotein Standard protein
05/29/2013CN1911965B Binding domain-immunoglobulin fusion proteins
05/29/2013CN1871346B Engineering single-gene-controlled staygreen potential into plants
05/29/2013CN1813061B Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
05/29/2013CN1661014B Novel method to isolate mutants and to clone the complementing gene
05/29/2013CN1582165B Antibodies to CD40
05/29/2013CN1525866B Treatment using neublastin polypeptides
05/29/2013CN103124790A Process and microorganisms for production of lipids
05/29/2013CN103124788A Bi-specific fusion proteins
05/29/2013CN103124787A Method for producing virus vector
05/29/2013CN103124738A Glucosinolate transporter protein and uses thereof
05/29/2013CN103122388A Method and primers for large-scale screening of CCR-delta 32 genotype
05/29/2013CN103122387A Rapid circulating tumor cell (CTCs) fluorescence PCR (Polymerase Chain Reaction) hypersensitivity detection kit and application thereof
05/29/2013CN103122385A Fluorogenic quantitative PCR (Polymerase Chain Reaction) detection method of nature killer enhancing factor (NKEF) genes of miichthys miiuy
05/29/2013CN103122383A Horizontal fluorescent quantitation polymerase chain reaction (PCR) detection method of streptococcus suis strain
05/29/2013CN103122377A Rapid detection method of marine animal cDNA (Complementary Deoxyribonucleic Acid) synthesis quality and special primer thereof
05/29/2013CN103122375A Kit for real-time fluorescence PCR (Polymerase Chain Reaction) detection of phoma macdonaldii boerma
1 ... 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 ... 4023